In last trading session, uniQure N.V (NASDAQ:QURE) saw 1.04 million shares changing hands with its beta currently measuring 0.31. Company’s recent per share price level of $13.78 trading at $0.44 or 3.30% at ring of the bell on the day assigns it a market valuation of $745.18M. That closing price of QURE’s stock is at a discount of -39.19% from its 52-week high price of $19.18 and is indicating a premium of 72.93% from its 52-week low price of $3.73. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.03 million shares which gives us an average trading volume of 1.14 million if we extend that period to 3-months.
For uniQure N.V (QURE), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.33. Splitting up the data highlights that, out of 7 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 6 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.95 in the current quarter.
uniQure N.V (NASDAQ:QURE) trade information
Upright in the green during last session for gaining 3.30%, in the last five days QURE remained trading in the green while hitting it’s week-highest on Thursday, 03/13/25 when the stock touched $13.78 price level, adding 2.06% to its value on the day. uniQure N.V’s shares saw a change of -21.97% in year-to-date performance and have moved 10.15% in past 5-day. uniQure N.V (NASDAQ:QURE) showed a performance of 4.71% in past 30-days. Number of shares sold short was 2.57 million shares which calculate 2.88 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 27 to the stock, which implies a rise of 48.96% to its current value. Analysts have been projecting 24 as a low price target for the stock while placing it at a high target of 30. It follows that stock’s current price would drop -74.17% in reaching the projected high whereas dropping to the targeted low would mean a loss of -74.17% for stock’s current value.
uniQure N.V (QURE) estimates and forecasts
This year revenue growth is estimated to rise 51.91% from the last financial year’s standing.
9 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 5.87M for the same. And 9 analysts are in estimates of company making revenue of 6.7M in the next quarter. Company posted 7.87M and 10.32M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -9.66% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 20.86% while estimates for its earnings growth in next 5 years are of 31.66%.
uniQure N.V (NASDAQ:QURE)’s Major holders
Insiders are in possession of 8.59% of company’s total shares while institution are holding 77.64 percent of that, with stock having share float percentage of 84.94%. Investors also watch the number of corporate investors in a company very closely, which is 77.64% institutions for uniQure N.V that are currently holding shares of the company. VESTAL POINT CAPITAL, LP is the top institutional holder at QURE for having 4.75 million shares of worth $21.28 million. And as of 2024-06-30, it was holding 9.7692 of the company’s outstanding shares.
The second largest institutional holder is NANTAHALA CAPITAL MANAGEMENT, LLC, which was holding about 2.65 million shares on 2024-06-30. The number of shares represents firm’s hold over 5.4511 of outstanding shares, having a total worth of $11.87 million.
On the other hand, abrdn Healthcare Investors and Franklin Strategic Series-Franklin Biotechnology Discove are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 812.69 shares of worth $11.2 million or 1.50% of the total outstanding shares. The later fund manager was in possession of 723.82 shares on Oct 31, 2024 , making its stake of worth around $9.97 million in the company or a holder of 1.34% of company’s stock.
